Still since CXCL10 is known to play a critical role in attracting T cells into the tumor microenvironment and is under the control of type I IFN, it seems reasonable to speculate that the IFNβ transgene modulates the chemokine milieu to recruit immune effectors into the tumor microenvironment. This evidence concerns the gene CXCL10 and neoplasm.